We are live on ! Find out more
AEMD icon

Aethlon Medical

5 hedge funds and large institutions have $334K invested in Aethlon Medical in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.48% less ownership

Funds ownership: 5.33%4.85% (-0.48%)

17% less funds holding

Funds holding: 65 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

65% less capital invested

Capital invested by funds: $959K → $334K (-$625K)

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q2 2019 in Review

5 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2019, worth a combined $334K — down 65% from $959K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AEMD and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $33.5K. The largest seller was Cordasco Financial Network, exiting entirely with an estimated $194K sold.

  • 5 institutional investors held Aethlon Medical (AEMD) as of Q2 2019, down from 6 in Q1 2019.
  • Funds reported $334K of Aethlon Medical stock for Q2 2019, down 65% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q2 2019 and 3 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q2 2019 was Citadel Advisors, an estimated $33.5K added.
  • The largest Aethlon Medical seller in Q2 2019 was Cordasco Financial Network, an estimated $194K sold.

Based on aggregated 13F filings for Q2 2019.